Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,406,089
- Total 13F shares
- 235,865,728
- Share change
- +19,277,967
- Total reported value
- $25,790,913,428
- Put/Call ratio
- 97%
- Price per share
- $109.35
- Number of holders
- 512
- Value change
- +$2,166,564,931
- Number of buys
- 256
- Number of sells
- 216
Report period
Q1 2017
Institutions
512
Top holders
10
VRTX full security history
Newer quarter: Q2 2017
Previous quarter: Q4 2016
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92532F100
Recent filing periods:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.6%
|
21,860,325
|
$1,610,450,000 | — | 31 Dec 2016 | |
| Capital World Investors |
13F
|
Company |
8.2%
|
20,758,133
|
$1,529,252,000 | — | 31 Dec 2016 | |
| FMR LLC |
13F
|
Company |
7.9%
|
20,096,788
|
$1,480,530,000 | — | 31 Dec 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.3%
|
15,914,094
|
$1,172,391,000 | — | 31 Dec 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.9%
|
14,920,158
|
$1,099,167,000 | — | 31 Dec 2016 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
11,774,161
|
$867,393,000 | — | 31 Dec 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.2%
|
10,596,948
|
$780,923,000 | — | 31 Dec 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.4%
|
8,706,635
|
$641,475,000 | — | 31 Dec 2016 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3.4%
|
8,649,358
|
$637,198,000 | — | 31 Dec 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
2.7%
|
6,818,014
|
$502,283,000 | — | 31 Dec 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
2.6%
|
6,532,503
|
$481,249,000 | — | 31 Dec 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
3,882,244
|
$286,005,000 | — | 31 Dec 2016 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.5%
|
3,848,605
|
$283,527,000 | — | 31 Dec 2016 | |
| BlackRock Group LTD |
13F
|
Company |
1.2%
|
2,967,665
|
$218,627,000 | — | 31 Dec 2016 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
2,903,439
|
$213,898,000 | — | 31 Dec 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
2,645,767
|
$194,914,000 | — | 31 Dec 2016 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.88%
|
2,236,747
|
$164,781,000 | — | 31 Dec 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.85%
|
2,159,400
|
$159,083,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
2,148,667
|
$158,093,000 | — | 31 Dec 2016 | |
| MANNING & NAPIER ADVISORS LLC |
13F
|
Company |
0.84%
|
2,126,020
|
$156,623,000 | — | 31 Dec 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.83%
|
2,117,536
|
$155,999,000 | — | 31 Dec 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.82%
|
2,078,621
|
$153,134,000 | — | 31 Dec 2016 | |
| NORGES BANK |
13F
|
Company |
0.68%
|
1,731,555
|
$127,564,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.6%
|
1,531,238
|
$112,807,000 | — | 31 Dec 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.57%
|
1,450,278
|
$106,842,000 | — | 31 Dec 2016 | |
| BB BIOTECH AG |
13F
|
Company |
0.56%
|
1,415,445
|
$104,276,000 | — | 31 Dec 2016 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
1,363,601
|
$100,456,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
1,344,242
|
$99,030,000 | — | 31 Dec 2016 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.51%
|
1,303,010
|
$95,993,000 | — | 31 Dec 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.51%
|
1,299,500
|
$95,734,000 | — | 31 Dec 2016 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.48%
|
1,226,158
|
$90,331,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.45%
|
1,134,070
|
$83,542,000 | — | 31 Dec 2016 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.44%
|
1,121,485
|
$82,620,000 | — | 31 Dec 2016 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.43%
|
1,094,829
|
$80,656,000 | — | 31 Dec 2016 | |
| Legal & General Group Plc |
13F
|
Company |
0.41%
|
1,048,474
|
$77,241,000 | — | 31 Dec 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.41%
|
1,033,503
|
$76,138,000 | — | 31 Dec 2016 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.4%
|
1,026,855
|
$75,648,000 | — | 31 Dec 2016 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.37%
|
933,492
|
$68,771,000 | — | 31 Dec 2016 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.35%
|
887,000
|
$65,345,000 | — | 31 Dec 2016 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.3%
|
763,300
|
$56,232,000 | — | 31 Dec 2016 | |
| Camber Capital Management LP |
13F
|
Company |
0.29%
|
750,000
|
$55,253,000 | — | 31 Dec 2016 | |
| EverPoint Asset Management, LLC |
13F
|
Company |
0.29%
|
730,000
|
$53,779,000 | — | 31 Dec 2016 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.29%
|
728,700
|
$53,683,000 | — | 31 Dec 2016 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.29%
|
725,404
|
$53,440,000 | — | 31 Dec 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
695,831
|
$51,262,000 | — | 31 Dec 2016 | |
| Swiss National Bank |
13F
|
Company |
0.27%
|
689,809
|
$50,818,000 | — | 31 Dec 2016 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.27%
|
687,506
|
$50,650,000 | — | 31 Dec 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.27%
|
674,526
|
$49,691,000 | — | 31 Dec 2016 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
673,879
|
$49,645,000 | — | 31 Dec 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.26%
|
671,795
|
$49,491,000 | — | 31 Dec 2016 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2017
As of 31 Mar 2017,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
512 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
235,865,728 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FMR LLC, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, STATE STREET CORP, JPMORGAN CHASE & CO, Clearbridge Investments, LLC, and AMERIPRISE FINANCIAL INC.
This page lists
513
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
470
Q1 2017 holders
512
Holder diff
42
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.